Shunsuke Shimosaki
Miyazaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clathrin-associated SCYL2 contributes to the activation of PI3K/AKT signaling and tumorigenesis through PTEN phosphorylation in adult T-cell leukemia/lymphoma.
Journal: Cancer gene therapy
Published: May 19, 2025
IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors.
Journal: Frontiers in oncology
Published: August 04, 2023
Corrigendum to "Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphomaˮ [Biochem. Biophys. Res. Commun. 485 (1) 2017 144-151].
Journal: Biochemical and biophysical research communications
Published: June 20, 2020
Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2low ATL and various cancer cells.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: July 30, 2019
Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression.
Journal: Scientific reports
Published: November 29, 2017
Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: April 20, 2017
Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
Journal: Biochemical and biophysical research communications
Published: January 25, 2017
Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer.
Journal: Cancer medicine
Published: November 05, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026